| Sign In to gain access to subscriptions and/or personal tools. |
Point-of-care (POC) versus central laboratory instrumentation for monitoring oral anticoagulationDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA, ddorfman{at}partners.org
Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA Point-of-care (POC) instruments employing fingerstick whole blood to monitor patients treated with warfarin are a popular alternative to complex, central laboratory coagulation analyzers utilizing citrated plasma derived from venipuncture. We investigated the accuracy of two widely utilized POC instruments for oral anticoagulation monitoring compared with a central laboratory instrument. Instrument-to-instrument variation differed for the two POC instruments, which correlated with the central laboratory instrument, but exhibited positive bias of 0.24-0.35 INR units. Positive bias increased as the INR values increased. We conclude that clinicians should exercise caution when interpreting results generated by POC monitors, particularly at high INR values. A high POC measurement of INR does not necessarily warrant decreasing the warfarin dose. Instead, a predefined cut-off range for high INR values generated by POC instruments should mandate confirmatory testing with central laboratory instrumentation.
Key Words: international normalized ratio (INR) prothrombin time (PT) warfarin
Vascular Medicine, Vol. 10, No. 1,
23-27 (2005) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||